KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Minority Interest (2016 - 2018)

Neogenomics (NEO) has disclosed Minority Interest for 4 consecutive years, with $35.5 million as the latest value for Q1 2018.

  • For the quarter ending Q1 2018, Minority Interest rose 39.44% year-over-year to $35.5 million, compared with a TTM value of $35.5 million through Mar 2018, up 39.44%, and an annual FY2017 reading of $32.6 million, up 42.59% over the prior year.
  • Minority Interest was $35.5 million for Q1 2018 at Neogenomics, up from $32.6 million in the prior quarter.
  • Across five years, Minority Interest topped out at $45.3 million in Q3 2016 and bottomed at $22.9 million in Q4 2016.
  • Average Minority Interest over 4 years is $32.2 million, with a median of $31.4 million recorded in 2017.
  • Peak annual rise in Minority Interest hit 42.59% in 2017, while the deepest fall reached 33.5% in 2017.
  • Year by year, Minority Interest stood at $28.6 million in 2015, then fell by 20.03% to $22.9 million in 2016, then soared by 42.59% to $32.6 million in 2017, then grew by 8.76% to $35.5 million in 2018.
  • Business Quant data shows Minority Interest for NEO at $35.5 million in Q1 2018, $32.6 million in Q4 2017, and $30.1 million in Q3 2017.